Market revenue in 2023 | USD 17,516.1 million |
Market revenue in 2030 | USD 47,599.3 million |
Growth rate | 15.4% (CAGR from 2023 to 2030) |
Largest segment | Proteomics |
Fastest growing segment | Transcriptomics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenetics |
Key market players worldwide | Agilent Technologies Inc, Beijing DWIN Technology Co., Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, Illumina Inc, Q2 Solutions, Spectrus, Flomics, PhenoSwitch Bioscience |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to omics lab services market will help companies and investors design strategic landscapes.
Proteomics was the largest segment with a revenue share of 43.79% in 2023. Horizon Databook has segmented the Asia Pacific omics lab services market based on genomics, proteomics, transcriptomics, metabolomics, epigenetics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific omics lab services market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific omics lab services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account